tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

APTO Stock Latest News

Aptose Biosciences Faces Nasdaq Delisting Challenge
Company AnnouncementsAptose Biosciences Faces Nasdaq Delisting Challenge
3d ago
8K
APTO
Aptose Announces Receipt of Deficiency Notice from Nasdaq
PremiumPress Releases
Aptose Announces Receipt of Deficiency Notice from Nasdaq
3d ago
APTO
Aptose Biosciences Shareholders Approve Key Proposals
PremiumCompany Announcements
Aptose Biosciences Shareholders Approve Key Proposals
1M ago
APTO
Aptose Announces Results from Annual and Special Meeting of Shareholders
PremiumPress Releases
Aptose Announces Results from Annual and Special Meeting of Shareholders
1M ago
APTO
Aptose Biosciences Issues Non-Filed Information Disclosure
PremiumCompany Announcements
Aptose Biosciences Issues Non-Filed Information Disclosure
1M ago
8K
APTO
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
PremiumPress ReleasesAptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
1M ago
APTO
Aptose Biosciences announces poster presentation, e-poster at EHA
PremiumThe Fly
Aptose Biosciences announces poster presentation, e-poster at EHA
1M ago
APTO
Aptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
PremiumThe Fly
Aptose Biosciences price target lowered to $7 from $23 at H.C. Wainwright
1M ago
APTO
Aptose Biosciences Secures $4.43 Million Funding
PremiumCompany Announcements
Aptose Biosciences Secures $4.43 Million Funding
2M ago
APTO
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2M ago
APTO
Aptose Biosciences to sell 3.86M shares at $1.15 in registered direct offering
PremiumThe Fly
Aptose Biosciences to sell 3.86M shares at $1.15 in registered direct offering
2M ago
APTO
Aptose Biosciences Concludes Agreement, Announces Update
PremiumCompany Announcements
Aptose Biosciences Concludes Agreement, Announces Update
2M ago
8K
APTO
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress ReleasesAptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2M ago
APTO
Aptose Biosciences price target lowered to $6 from $15 at Canaccor15
PremiumThe Fly
Aptose Biosciences price target lowered to $6 from $15 at Canaccor15
2M ago
APTO
Aptose Biosciences Launches AML Triplet Therapy Study
PremiumCompany Announcements
Aptose Biosciences Launches AML Triplet Therapy Study
2M ago
APTO
Aptose Reports Results for the First Quarter 2024
PremiumPress Releases
Aptose Reports Results for the First Quarter 2024
2M ago
APTO
APTO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
APTO Upcoming Earnings Report: What to Expect?
2M ago
APTO
Aptose Biosciences Unveils Q1 Results and Clinical Update
PremiumCompany Announcements
Aptose Biosciences Unveils Q1 Results and Clinical Update
3M ago
APTO
Aptose Biosciences Announces Vital Update; Not SEC Filed
PremiumCompany Announcements
Aptose Biosciences Announces Vital Update; Not SEC Filed
3M ago
8K
APTO
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
PremiumPress ReleasesAptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
3M ago
APTO
Aptose Biosciences Enhances Executive Compensation and Roles
PremiumCompany Announcements
Aptose Biosciences Enhances Executive Compensation and Roles
3M ago
8K
APTO
Aptose Biosciences Expands AML Treatment Trials
PremiumCompany Announcements
Aptose Biosciences Expands AML Treatment Trials
4M ago
APTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >